Eddy Anglade, Founder of Tenpoint Therapeutics

Eddy Anglade is the founder of Tenpoint Therapeutics. Tenpoint Therapeutics has raised $70M in total funding. Latest round: Series A. Based in London, UK.

About Eddy Anglade

Eddy Anglade is the CEO of Tenpoint Therapeutics, a biotechnology company focused on developing regenerative medicine for degenerative ocular diseases. The company launched with a $70 million Series A financing round to advance its platform, which aims to replace cells lost to inherited and age-related conditions. Anglade brings extensive experience in clinical development in ophthalmic diseases to his role at Tenpoint.

Eddy Anglade at a glance

More founders in London, UK (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library